Friday Pop Quiz 5/8/2026
A 40 year old male presents to clinic with involvement of greater than 50% of his scalp. Topical therapies and intralesional injections in clinic have not resulted in much improvement. Before starting the appropriate FDA approved long-term oral medication, which laboratory blood work should be ordered?
A. Quantiferon gold test only
B. Fasting glucose, Hemoglobin A1C, lipid panel, and cor …
A 40 year old male presents to clinic with involvement of greater than 50% of his scalp. Topical therapies and intralesional injections in clinic have not resulted in much improvement. Before starting the appropriate FDA approved long-term oral medication, which laboratory blood work should be ordered?
A. Quantiferon gold test only
B. Fasting glucose, Hemoglobin A1C, lipid panel, and cor … 
Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and … 
In 2022 the FDA approved a medication for the treatment of the condition dipicted in the image. It inhibits the same enzymes as which of the following?
A. Ruxolitinib
B. Abrocitinib
C. Apremilast
D. Adalimumab
E. Tofacitinib
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
As 2024 comes to a close, the Journal of Drugs in Dermatology delivers a stellar lineup of research, reviews, and insights to inform your practice and inspire your curiosity. This month's Editor's Picks feature cutting-edge studies and expert commentary on a range of topics, from advanced acne treatments to groundbreaking leadership initiatives in dermatology.
Laser and Energy Treatments for Ac … 
Pentoxifylline is a methyl-xanthine derivative traditionally used to treat symptoms of peripheral vascular disease and has emerged as a valuable therapeutic agent in dermatology for its anti-inflammatory and immunomodulatory properties. We continue our series, Therapeutic Cheat Sheet, with a closer look at pentoxifylline, which is FDA-approved for the treatment of intermittent claudication and is …